The Metabolic Profile Of Patients With Epilepsy Treated With Eslicarbazepine Acetate: Integrated Analyses Of Plasma Lipid And Glucose Parameters, And Distribution Of Related Adverse Events In Placebo-Controlled Phase Iii Clinical Studies
AuthID
P-002-P11
P-002-P11